Early Access — free while we kick the tires
EdgarHawk

CYRX Cryoport, Inc. Insider Trading

Latest: CFO Sold $2.8M of Shares · Jun 2026

Cryoport, Inc. (CYRX)'s reported leadership includes CEO Jerrell W. Shelton. Its Form 4 history breaks down as 0 buys and 3 sells, filed by 2 distinct insiders through Jun 2026. Its highest-significance filing in the last 90 days: CFO Robert Stefanovich sold $2.8M, transaction dated Jun 2026.

3 filings analyzed · Latest 2026-06-08

Get alerts for CYRX

Free Form 4 email alerts, scored for significance — see how.

Buys
0
Sells
3
Insiders
2
Direction
Net selling

Cryoport, Inc. leadership

CEO
Jerrell W. Shelton — CHIEF EXECUTIVE OFFICER
CFO
Robert S. Stefanovich — CHIEF FINANCIAL OFFICER
Chair
Jerrell W. Shelton — Chairman, President and CEO

Historically, stocks have lagged the S&P 500 by a median ~4% over the 90 days after a high insider sell (n ≈ 3,996, 2024-2026). Past results don't predict the future. How we measure this ↗

June 2026
2026-06-08
high
Chief Financial Officer
169,427 shares
$2,756,984
@ $16.27
Significance 7

Cryoport CFO Robert Stefanovich sold 169,427 shares at $16.27 for $2,756,983.91, reducing holdings by -60.7% as stock nears 52-week high.

Robert Stefanovich, Chief Financial Officer of Cryoport, Inc. (CYRX), sold 169,427 shares at $16.27 on 2026-06-04, collecting $2,756,983.91 and cutting his stake by -60.7% from 279,277 shares to 109,850 shares post-transaction. The sale occurred with the stock -7.5% from its 52-week high of $16.73 and following a 90-day change of +96.4%, providing a significantly elevated price backdrop relative to recent history. The scale of the reduction — more than half his pre-transaction holdings — is notable against a fundamental backdrop that includes annual revenue growth of -22.9% and a net income of $-10,544,000.00 in the latest quarter. Investors may wish to weigh the magnitude of this insider reduction alongside the company's current revenue trajectory and the stock's proximity to its 52-week high.

June 2025
2025-06-20
high
President, CEO
339,720 shares
$2,289,781
@ $6.74
Significance 6

CEO Shelton Jerrell sold 339,720 shares (339.7K) for $2.3M over 3 trading days as CYRX trades 34.9% below 52-week high.

CEO Shelton Jerrell executed 3 separate sales totaling 339,720 shares (339.7K shares) for $2,289,781.35 ($2.3M) between 2025-06-17 and 2025-06-20, reducing his holdings by 27.1% to 912,419 shares (912.4K shares). The blended average sale price of $6.74 occurred while the stock trades at $6.37, currently positioned 34.9% below its 52-week high of $9.79 and within the lower half of its 52-week range ($4.70–$9.79). Cryoport remains unprofitable, with net income of $-11,981,000.00 ($-12.0M) against quarterly revenue of $41,040,000.00 ($41.0M), and faces annual revenue contraction of 2.1%. Notably, across his same-ticker history at CYRX, 4 of 5 prior sells showed negative 90-day returns (well-timed outcomes: dates 2024-11-20, 2024-11-19, 2024-11-18, 2024-03-15 second instance). The current filing merits monitoring as a concentrated divestiture by the CEO during a period of depressed valuation and operational challenges.

November 2024
2024-11-20 10b5-1 Plan
low
President, CEO
150,000 shares
$1,007,820
@ $6.72
Significance 3

CYRX CEO Shelton Jerrell sells 150,000 shares for $1.0M across 3 trades under 10b5-1 plan (adopted 2024-03-15).

Shelton Jerrell, as President and CEO, executed 3 separate sales totaling 150,000 shares for $1,007,820.00 at an average price of $6.72 per share on November 18-20, 2024. His post-transaction holdings of 722,747 shares represent a 17.2% reduction from pre-transaction holdings of 872,747 shares. Critically, this transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2024-03-15, meaning the sales were scheduled rather than discretionary. As a scheduled transaction under a Rule 10b5-1 plan, this does not reflect a current trading decision or judgment about near-term stock direction.

More Chemicals and Allied Products companies